Close

Ratings by Cantor Fitzgerald (Elemer Piros)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/24/2020 Arrowhead Pharma ARWR Maintain Overweight
(N/A)
 
 
  Details
8/17/2020 Unity Biotechnology Inc UBX Maintain Overweight
(N/A)
 
 
  Details
5/14/2020 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
5/8/2020 Arrowhead Research ARWR Maintain Overweight
(N/A)
 
 
  Details
5/5/2020 Marinus Pharmaceuticals MRNS Maintain Overweight
(N/A)
 
 
  Details
4/15/2020 Arrowhead Research ARWR Upgrade Buy
(Neutral)
36.77
(30.93)
-15.88% Details
2/6/2020 Arrowhead Research ARWR Maintain Neutral
(N/A)
 
 
  Details
12/12/2019 Unity Biotechnology Inc UBX New Coverage Overweight
(N/A)
7.72
(0.41)
-94.69% Details
12/5/2019 Aurinia Pharmaceuticals AUPH Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
10/18/2019 Marinus Pharmaceuticals MRNS New Coverage Overweight
(N/A)
1.33
(7.06)
430.83% Details
10/8/2019 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
9/23/2019 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
9/12/2019 Tocagen Inc. TOCA Downgrade Neutral
(Overweight)
4.18
(1.26)
-69.86% Details
9/6/2019 Durect Corp DRRX New Coverage Overweight
(N/A)
1.66
(1.94)
16.87% Details
8/20/2019 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
8/12/2019 Abeona Therapeutics ABEO Downgrade Neutral
(Overweight)
2.29
(3.03)
32.31% Details
7/11/2019 Dynavax Technologies DVAX Upgrade Overweight
(Neutral)
3.79
(10.24)
170.18% Details
7/8/2019 uniQure BV QURE Maintain Overweight
(Overweight)
 
 
  Details
6/28/2019 Arrowhead Research ARWR Downgrade Neutral
(Overweight)
27.70
(30.93)
11.66% Details
6/25/2019 Aldeyra Therapeutics ALDX Maintain Overweight
(N/A)
 
 
  Details
6/24/2019 Krystal Biotech KRYS Maintain Overweight
(N/A)
 
 
  Details
6/21/2019 Mustang Bio MBIO New Coverage Overweight
(N/A)
3.62
(2.57)
-29.01% Details
6/14/2019 bluebird bio BLUE Maintain Neutral
(N/A)
 
 
  Details
6/14/2019 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
6/11/2019 Aerie Pharma AERI Maintain Overweight
(N/A)
 
 
  Details
6/5/2019 Amicus Therapeutics FOLD Maintain Overweight
(Overweight)
 
 
  Details
5/7/2019 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
4/26/2019 Tocagen Inc. TOCA New Coverage Overweight
(N/A)
8.52
(4.18)
-50.94% Details
3/26/2019 Aldeyra Therapeutics ALDX Maintain Overweight
(N/A)
 
 
  Details
3/25/2019 Proteostasis Therapeutics PTI Maintain Overweight
(N/A)
 
 
  Details
3/20/2019 Aurinia Pharmaceuticals AUPH Maintain Overweight
(N/A)
 
 
  Details
3/19/2019 Abeona Therapeutics ABEO Maintain Overweight
(N/A)
 
 
  Details
3/19/2019 Amicus Therapeutics FOLD Maintain Overweight
(N/A)
 
 
  Details
3/14/2019 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
3/11/2019 Spring Bank Pharmaceuticals SBPH Maintain Overweight
(N/A)
 
 
  Details
3/11/2019 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
3/7/2019 uniQure BV QURE Maintain Overweight
(N/A)
 
 
  Details
3/7/2019 Unity Biotechnology Inc UBX New Coverage Overweight
(N/A)
10.22
(7.72)
-24.46% Details
3/6/2019 Marinus Pharmaceuticals MRNS Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Nightstar Therapeutics NITE Downgrade Neutral
(Overweight)
14.82
(25.41)
71.46% Details
2/27/2019 Dynavax Technologies DVAX Maintain Overweight
(N/A)
 
 
  Details
2/26/2019 Strongbridge Biopharma SBBP Maintain Overweight
(N/A)
 
 
  Details
2/25/2019 uniQure BV QURE Maintain Overweight
(N/A)
 
 
  Details
2/19/2019 Galmed Pharmaceuticals GLMD Maintain Overweight
(N/A)
 
 
  Details
1/30/2019 Amicus Therapeutics FOLD New Coverage Overweight
(N/A)
11.21
(8.94)
-20.25% Details
1/10/2019 Corbus Pharmaceuticals CRBP Maintain Overweight
(N/A)
 
 
  Details
12/10/2018 Marinus Pharmaceuticals MRNS Maintain Overweight
(N/A)
 
 
  Details
12/3/2018 Ocular Therapeutix OCUL Maintain Overweight
(N/A)
 
 
  Details
12/3/2018 GW Pharma GWPH Maintain Overweight
(Overweight)
 
 
  Details
12/3/2018 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
11/27/2018 Proteostasis Therapeutics PTI Maintain Overweight
(N/A)
 
 
  Details
11/15/2018 uniQure BV QURE Maintain Overweight
(N/A)
 
 
  Details
11/7/2018 Proteostasis Therapeutics PTI New Coverage Overweight
(N/A)
6.93
(1.11)
-83.98% Details
11/2/2018 bluebird bio BLUE Upgrade Neutral
(Underweight)
130.15
(5.62)
-95.68% Details
10/22/2018 Dynavax Technologies DVAX Maintain Overweight
(N/A)
 
 
  Details
10/15/2018 Krystal Biotech KRYS Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Nightstar Therapeutics NITE New Coverage Overweight
(N/A)
15.04
(14.82)
-1.46% Details
10/4/2018 Arrowhead Research ARWR Maintain Overweight
(N/A)
 
 
  Details
9/27/2018 GW Pharma GWPH Maintain Overweight
(N/A)
 
 
  Details
9/26/2018 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
9/26/2018 Aldeyra Therapeutics ALDX Maintain Overweight
(N/A)
 
 
  Details
9/13/2018 Corbus Pharmaceuticals CRBP Maintain Overweight
(N/A)
 
 
  Details
9/12/2018 PolarityTE COOL Maintain Overweight
(N/A)
 
 
  Details
9/10/2018 Krystal Biotech KRYS New Coverage Overweight
(N/A)
18.85
(67.69)
259.1% Details